Navigation Links
Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
Date:2/1/2012

SAN DIEGO, and WOODCLIFF LAKE, N.J., Feb. 1, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified Arena that an Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the lorcaserin New Drug Application (NDA) resubmission will be held in the second quarter of 2012. Confirmation and details of the meeting will be published in the Federal Register.

Lorcaserin is an investigational drug candidate intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition. Arena resubmitted the lorcaserin NDA in December 2011, and the FDA assigned a new Prescription Drug User Fee Act (PDUFA) target date of June 27, 2012.

About LorcaserinLorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism. Arena has patents that cover lorcaserin in the United States and other jurisdictions that in most cases are capable of continuing into 2023 without taking into account any patent term extensions or other exclusivity Arena might obtain.

Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States subject to FDA approval of the lorcaserin NDA.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic are
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014 Cynosure, Inc. (Nasdaq: ... light-based aesthetic treatment systems for high-volume applications, today reported ... 2014. Second-quarter 2014 financial results incorporate the acquisition of ... 2013. Second-Quarter 2014 Financial Highlights ... $72.6 million , Non-GAAP net income of $7.1 ...
(Date:7/29/2014)... Texas , July 29, 2014  Novation, ... new web-based applications with breakthrough interactive features that ... workflows for members of Children,s Hospital Association.  ... the Novation Optimize Solutions umbrella – Value Analysis, ... how Novation helps organizations address the most critical ...
(Date:7/29/2014)... July 29, 2014  The BioFusionary Corporation, Inc. ... a proprietary electromagnetic induction platform with aesthetic and ... agreement under which TBC will merge with ... in an all-stock transaction. Upon completion ... on the Australian Stock Exchange under the code ...
Breaking Medicine Technology:Cynosure Reports Second-Quarter 2014 Financial Results 2Cynosure Reports Second-Quarter 2014 Financial Results 3Cynosure Reports Second-Quarter 2014 Financial Results 4Cynosure Reports Second-Quarter 2014 Financial Results 5Cynosure Reports Second-Quarter 2014 Financial Results 6Cynosure Reports Second-Quarter 2014 Financial Results 7Cynosure Reports Second-Quarter 2014 Financial Results 8Cynosure Reports Second-Quarter 2014 Financial Results 9Cynosure Reports Second-Quarter 2014 Financial Results 10Cynosure Reports Second-Quarter 2014 Financial Results 11Cynosure Reports Second-Quarter 2014 Financial Results 12Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3
... WOODCLIFF LAKE, N.J., Nov. 3, 2010 Par Pharmaceutical Companies, ... the third quarter ended September 30, 2010. For ... total revenues of $234.4 million and income from continuing operations ... included a $2.0 milestone payment to Tris Pharma, Inc., a ...
... 2010 Regado Biosciences, Inc., a privately held company ... agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior ... at the American College of Chest Physicians (ACCP) Coagulation ... Vancouver, BC, Canada.  The abstract is titled "Sustained Inhibition ...
Cached Medicine Technology:Par Pharmaceutical Companies Reports Third Quarter 2010 Results 2Par Pharmaceutical Companies Reports Third Quarter 2010 Results 3Par Pharmaceutical Companies Reports Third Quarter 2010 Results 4Par Pharmaceutical Companies Reports Third Quarter 2010 Results 5Par Pharmaceutical Companies Reports Third Quarter 2010 Results 6Par Pharmaceutical Companies Reports Third Quarter 2010 Results 7Par Pharmaceutical Companies Reports Third Quarter 2010 Results 8Par Pharmaceutical Companies Reports Third Quarter 2010 Results 9Par Pharmaceutical Companies Reports Third Quarter 2010 Results 10Par Pharmaceutical Companies Reports Third Quarter 2010 Results 11Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 2Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010 3
(Date:7/29/2014)... (PRWEB) July 29, 2014 Biocides are ... and control bacteria or fungi growth and to prevent ... within the material and its surface. It is used ... wood preservation, food and beverage, paints and coatings. It ... and sanitizers, as well as in industrial applications to ...
(Date:7/29/2014)... The U.S. should significantly reform the federal system ... ensure that the public,s $15 billion annual investment ... says a new report by the Institute of ... Medicare -- requires little accountability, allocates funds independent ... insufficient opportunities to train physicians in the health ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Frank Davis, ... powders can help parents add nutrition to their kids’ ... Bites – Key market drivers in kids’ foods market” ... is pleased to announce the interview Frank Davis had ... the Activz organic vegetable and fruit produce powders to ...
(Date:7/29/2014)... State College of Medicine, have jointly received nearly ... data research network., The Patient-Centered Outcomes Research Institute ... and Affordable Care Act, awarded the funds to ... Johns Hopkins University -- and each of their ... together to create a Clinical Data Research Network, ...
(Date:7/29/2014)... July 29, 2014 According to a ... the leading global authority in medical device market research, ... grow to over $8 billion by 2018. This ... in the transcatheter heart valve market, which is comprised ... the transcatheter mitral valve repair (TMVR) segments. , There ...
Breaking Medicine News(10 mins):Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 2Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 3Health News:North America Biocides Market is Expected to Reach 890.3 KT in 2016 - New Report by MicroMarket Monitor 4Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:New network unites university health care research 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3
... ... aftershave, beard inhibitor, and SPF29 sun block spray. , ... (PRWEB) January 27, 2010 -- Hey Dude Skin Care ™, ... an outstanding array of premium skin care products targeted at the unique protection, repair and ...
... CHAIRMAN , NEW YORK , Jan. 27 ... University announced today that William H. Foster , PhD, Dean ... Service, will become President and Chief Executive Officer of CASA on ... former U.S. Secretary of Health, Education, and Welfare who founded CASA in ...
... , , PHOENIX ... Eating and Anxiety Disorders ( http://www.remudaranch.com ) and MASK (Mothers ... teachers and students about eating disorders and related issues. , ... trained by an organization of the caliber of Remuda Ranch," ...
... , , NEW YORK , Jan. 27 ... $250,000 grant to the Clinton Health Access Initiative (CHAI), a ... in 2002. The grant will ensure the continuation of HIV/AIDS ... of the devastating January 12 earthquake. , ...
... , , LOS ANGELES , Jan. 27 ... more information about the IDEAL breast implants on his blog. He discussed ... would be available to the public for a clinical trial. , Board-certified ... of the new IDEAL breast implants. These implants are known to have ...
... woman who suggests using a condom makes no difference to ... suggests it makes a difference. If she highlights her sexuality ... and fun activity, other women judge her more harshly than ... or shares her concerns about sexually transmitted infections. Dr. Michelle ...
Cached Medicine News:Health News:Hey Dude Skin Care™ Rolls Out Line of Premium Men's Skin Care Products 2Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 2Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 3Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 4Health News:Remuda Ranch, Programs for Eating and Anxiety Disorders, and MASK (Mothers Awareness on School-Age Kids), Partner to Help Educate Parents, Teachers and Students About Eating Disorders 2Health News:Remuda Ranch, Programs for Eating and Anxiety Disorders, and MASK (Mothers Awareness on School-Age Kids), Partner to Help Educate Parents, Teachers and Students About Eating Disorders 3Health News:Ford Foundation Commits $250,000 to Support HIV/AIDS Services in Haiti 2Health News:Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants 2Health News:Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants 3Health News:Condom or no condom? It's not what you say, it's how you say it 2
... Certified by an independent laboratory ... of Federal Standard 209E. Ergonomic ... fatique and back injuries. Clean ... requirements. Static-control chairs feature dissipative ...
... SCE offers a full line of ... manufacturing and laboratory environments. Every SCE product ... / safety requirements. Now you can have ... hazardous acid / corrosive chemicals and materials ...
... Genie is an all-in-one rotator/rocker with ... five different mixing motions: rotating, ... well as a combination of all ... portion of the Vibraotme Roto-Shake Genie ...
... 55S Rocking Shaker provides the exact ... membranes. The very slow to fast ... tilt provide a gentle wave motion ... and blotted membranes to achieve faster, ...
Medicine Products: